Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Ordinary Shares, par value NIS 0.10 per share
-
Shares outstanding
-
1.15B
-
Number of holders
-
768
-
Total 13F shares, excl. options
-
487M
-
Shares change
-
+14.8M
-
Total reported value, excl. options
-
$25.5B
-
Value change
-
+$774M
-
Put/Call ratio
-
0.31
-
Number of buys
-
319
-
Number of sells
-
-359
-
Price
-
$52.42
Significant Holders of TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) as of Q2 2014
893 filings reported holding TEVA - TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share as of Q2 2014.
TEVA PHARMACEUTICAL INDUSTRIES LTD - Ordinary Shares, par value NIS 0.10 per share (TEVA) has 768 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 487M shares
of 1.15B outstanding shares and own 42.42% of the company stock.
Largest 10 shareholders include FRANKLIN RESOURCES INC (55M shares), FMR LLC (39.7M shares), Capital Research Global Investors (32.9M shares), Invesco Ltd. (19.6M shares), Mondrian Investment Partners LTD (17.3M shares), LAZARD ASSET MANAGEMENT LLC (15.3M shares), WELLINGTON MANAGEMENT CO LLP (14M shares), Allianz Asset Management AG (12.8M shares), PointState Capital LP (12.5M shares), and BARROW HANLEY MEWHINNEY & STRAUSS LLC (10.9M shares).
This table shows the top 768 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.